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We report here the ﬁrst case of treatment of idiopathic refractory overactive bladder with dopamine. A
female patient consulted for urge incontinence. Management included all recommended treatments
without success. DAT scan was ﬁnally performed showing clear reduction in dopamine secretion without
diagnosis of any neurological condition. Patient started dopamine treatment. At 1 month, patient
described persistence of mild urgency and frequency but complete resolution of urge incontinence.
At 3 months patient was completely dry with only persistence of mild frequency. Functional imaging and
central nervous system target might represent new ways of managing idiopathic overactive bladder.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Overactive bladder is a urological syndrome which affects 13e
16% of the population1 and focus point of the neuro-urologicalworld
due to its socially invalidating symptoms (urgency and
incontinence). Nevertheless it remains a complex matter as its
etiology is multifactorial (neurogenic, non neurogenic, idiopathic)
and its physiopathologicalmechanism localized at various levels and
yet tobe clearly known. For thismatter in the last 20 years it has been
subject of various studies with following implications in treatment,
advocatedbyguidelines,which goes frombehavioral therapy, to oral
drugs (anti-muscarinics and recently beta adrenergics) intracavitaryd design, acquisition of data,
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Inc. This is an open access article udrugs (vanilloids: non longer in use) intradetrusorial drugs (botox)
and nerve stimulation (neuromodulation, PTNS).
Addressing this matter, Andersson introduced the concept of
possible central nervous system targets by reviewing all neurotrans-
mitters involved at a central level. He emphasized however the fact
that a selective action on the lower urinary tract might be difﬁcult to
obtain and is infact yet to demonstrate in non neurogenic patients.2
We report here what we believe to be the ﬁrst case of a patient
treated successfully with dopamine for idiopathic refractory over-
active bladder after evidencing depletion by DAT scan.Material and methods
A 49 year old female patient come to our observation in 1989 for a
symptomatic incontinence (more than 3 diapers/day wet) initially
falsely labeled as stress incontinence, which persisted without any
improvement nor modiﬁcation of symptoms after colposuspension
according to Burch. Our initial work-up included video-urodynamics
which concluded at urge incontinence from detrusor overactivity.
Patient subsequently underwent full neurological evaluation as well
as urological work-up to rule out any neurogenic (Parkinson’s dis-
ease) or non neurogenic origin to ﬁnally conclude to urge inconti-
nence in a context of idiopathic overactive bladder. Initial treatment
included lifestyle treatment and adjunction of oxybutynin without
any success. In 1990, patient underwent surgery for releasing of the
colposuspension believing that this might have determined the non
response to drugs, unfortunately again without success. Patientnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. DAT-scan image showing a clear reduction in dopamine at level of the left
putamen and at level the right caudate nucleus.
Figure 2. All treatments performed before dopamine substitution.
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vesical instillation of vanilloids and chronic intravesical instillation of
nociceptin3; Due to symptom persistence electrical neuro-
modulation by stimulation of S3 sacral roots as well as experimental
pudendal nerve stimulation were performed without any results.
Detrusor botulinum toxine did not have any more luck. Molecules
such as tolterodine and trospium chloride as well as mirabegron did
not show any improvement in symptom control.
Due to atherapeutical[ dead end, discussion with patient of
a potential derivation associated to cystectomy was taken into
account. In front of patients reluctance, inspired by Andersson’s
work2 we decided to perform DAT scan. The exam showed a clear
reduction in dopamine at level of the left putamen and at level the
right caudate nucleus (Fig. 1) although no neurological condition
was ever diagnosed (full neurological work-up). In this context
patient started retard levodopa (Madopar) treatment (100 mg per
day) and was scheduled for follow-up controls.
Results
At ﬁrst control at 1 month, patient already described an
improvement with persistence of mild urgency and frequency at
voiding diary but complete resolution of urge incontinence
requiring only small pads which however were used more for the
fear of an eventual leakage.
Patient continued treatment and was seen at 3 months from
treatment start and still referred to be completely dry (one pad a
day dry) with only the persistence of daytime frequency at bladder
diary which however had improved since the last control.
Discussion
This case is an interesting case of refractory idiopathic overactive
bladder. In our centers experience a few comparable situations have
been noted. For each patient, all guidelines recommendedtreatments (Fig. 2) were used without any success, bringing up the
idea that we do not know yet everything about the pathophysiology
of overactive bladder. Andersson describes that central
dopaminergic pathways may have facilitatory and inhibitory effects
onmicturition by actions through D1-like and D2 like dopaminergic
receptors. This has already been described in Parkinson’s disease
affected patients4 but not innon neurological[ patients, where
an involvement of dopamine depletion has yet to be demonstrated.
We believe in the importance of presenting this case for two rea-
sons: it is the ﬁrst description of dopamine use for successful
treatment of refractory idiopathic overactive bladder. Second it
introduces DAT scan imaging as a possible diagnostic[ tool in
patients non responders to current treatment options. This case
presentation does not claim to have found a new treatment option
but opens the way for new research whichmight conﬁrm the use of
imaging for overactive bladder diagnosis.
Furthermore if a correlation between symptoms and imaging is
found central nervous system target might ﬁnally be conﬁrmed as
treatment options in which could therefore be more deﬁned as
undisclosed neurogenic overactive bladder than idiopathic. It is
important to emphasize once again that this report should be a
preliminary for a structured randomized study.
Conclusion
This represents for us an interesting case as it shows for the ﬁrst
time a possible correlation between voiding symptoms and central
nervous system deﬁcit, demonstrated through imaging. If this is
conﬁrmed in other patients, central nervous system deﬁcit may be
recognized as a cause of bladder instability in non neurological
patients and central nervous targets might be conﬁrmed as treat-
ment options. Furthermore this might lead to a modiﬁcation of
terminology switching from idiopathic overactive bladder to amore
meaningful “undisclosed neurogenic” overactive bladder.
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